• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Jaguar Health Inc (NQ: JAGX )

    3.410 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 718
    Open 3.410
    Bid (Size) 3.470 (4)
    Ask (Size) 3.550 (1)
    Prev. Close 3.410
    Today's Range 3.410 - 3.410
    52wk Range 0.0512 - 7.248
    Shares Outstanding 171,350,166
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Jaguar Health Regains Compliance with Nasdaq's Bid Price Requirement
    Via ACCESSWIRE
    Jaguar Health Reports Approval of All Proposals at June 2024 Annual Meeting of Stockholders
    Via ACCESSWIRE

    Performance

    YTD
    +2155.29%
    +2155.29%
    1 Month
    -18.62%
    -18.62%
    3 Month
    +4508.11%
    +4508.11%
    6 Month
    +2155.29%
    +2155.29%
    1 Year
    +531.48%
    +531.48%

    More News

    Read More
    Jaguar Health to Report Pivotal Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug Crofelemer on or Before July 23, 2024
    Via ACCESSWIRE
    Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    Via ACCESSWIRE
    Nasdaq Stocks Soaring to the Top with Strategic Splits: NVDA, INBS, JAGX, SINT, GWAV
    Via AB Newswire
    Exposures Product Safety
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Jaguar Health, Inc. Announces Reverse Stock Split
    Via ACCESSWIRE
    Jaguar Health Reports First Quarter 2024 Financial Results
    Via ACCESSWIRE
    Jaguar Health Executes Out-License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for Schizophrenia
    Via ACCESSWIRE
    Investigator-Initiated Trial of Jaguar Health’s Crofelemer Yields Positive Results for Functional Diarrhea
    Via ACCESSWIRE
    What's Going On With Jaguar Health Stock?
    Via Benzinga
    Jaguar Health to Initiate Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO) Annual Meeting with Exhibit Booth for FDA-Approved Gelclair Oral Mucositis Product
    Via ACCESSWIRE
    Dow Falls Over 150 Points; Sohu Posts Q1 Loss
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why Jaguar Health Stock Is Tanking
    Via Benzinga
    Nasdaq Surges 100 Points; Wix.com Shares Jump Following Q1 Results
    Via Benzinga
    Red Lobster Bankruptcy: What Happened to the Popular Seafood Chain?
    Via InvestorPlace
    Topics Bankruptcy
    Exposures Financial Legal
    US Stocks Mixed; Li Auto Shares Plummet After Q1 Results
    Via Benzinga
    Why Is Jaguar Health (JAGX) Stock Down 40% Today?
    Via InvestorPlace
    Why Wix.com Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    JAGX Stock Earnings: Jaguar Health Misses EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.